Finemedix Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
77
- Stock Symbol
-
387570
- Share Price
-
$4.08
- (As of Friday Closing)
Finemedix General Information
Description
Finemedix Co Ltd is engaged in manufacturing of other medical and surgical equipment and orthopedic appliances. The company is engaged in production of endoscopic surgical instruments and domestically produced functionally endoscopic incisions, snares, etc. The company is supplying its products to several university hospitals, large hospitals, and clinics in Korea, and are continuously planning and developing products that actively reflect the ideas of developed domestic medical staff and voices from the field. In addition, the company is preparing for overseas exports by obtaining CE and FDA certifications and is emerging as a specialized medical device company.
Contact Information
Website
www.finemedix.comCorporate Office
- 140-9, Yulam-ro
- Daegu, Dong
- South Korea
Corporate Office
- 140-9, Yulam-ro
- Daegu, Dong
- South Korea
Finemedix Stock Performance
As of 13-Nov-2026, Finemedix’s stock price is $4.08. Its current market cap is $22.1M with 5.43M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.08 | $4.18 | $2.53 - $6.29 | $22.1M | 5.43M | 7.04K | -$0.08 |
Finemedix Financials Summary
As of 30-Jun-2026, Finemedix has a trailing 12-month revenue of $7.87M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 16,402 | 26,731 | 54,572 | |
| Revenue | 7,874 | 6,691 | 7,300 | 7,766 |
| EBITDA | (146) | (1,134) | 635 | 1,753 |
| Net Income | (413) | (1,320) | (18) | 899 |
| Total Assets | 15,651 | 17,723 | 18,261 | 14,376 |
| Total Debt | 1,445 | 2,730 | 2,668 | 3,324 |
Finemedix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Finemedix Patents
Finemedix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026225681-A1 | Hemostatic powder spray device couplable to endoscope air valve | Pending | 23-Apr-2025 | ||
| WO-2026225680-A1 | Hemostatic agent spray device combined with gas supply device and comprising button-controlled powder flow path regulator | Pending | 22-Apr-2025 | ||
| WO-2026225679-A1 | Lesion location tracking system comprising magnetic clip deployment device | Pending | 22-Apr-2025 | ||
| WO-2025095418-A1 | Endoscopic device | Inactive | 30-Oct-2023 | ||
| EP-4417153-A1 | Hemostatic forceps for endoscope | Pending | 15-Feb-2023 | A61B17/29 |
Finemedix Signals
Finemedix Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Finemedix ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Finemedix FAQs
-
When was Finemedix founded?
Finemedix was founded in 2009.
-
Where is Finemedix headquartered?
Finemedix is headquartered in Daegu, South Korea.
-
What is the size of Finemedix?
Finemedix has 77 total employees.
-
What industry is Finemedix in?
Finemedix’s primary industry is Surgical Devices.
-
Is Finemedix a private or public company?
Finemedix is a Public company.
-
What is Finemedix’s stock symbol?
The ticker symbol for Finemedix is 387570.
-
What is the current stock price of Finemedix?
As of 13-Nov-2026 the stock price of Finemedix is $4.08.
-
What is the current market cap of Finemedix?
The current market capitalization of Finemedix is $22.1M.
-
What is Finemedix’s current revenue?
The trailing twelve month revenue for Finemedix is $7.87M.
-
What is Finemedix’s annual earnings per share (EPS)?
Finemedix’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process